Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: Possible mechanisms

Circulation

Volumn 99, Issue 3, 1999, Pages 434-440

  Hoshida, Shiro ^b   Yamashita, Nobushige ^c   Kawahara, Kiminori ^a   Kuzuya, Tsunehiko ^c   Hori, Masatsugu ^c  

^a Yoshitomi Pharmaceutical Industries Ltd   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c NONE

Author keywords

Atherosclerosis; Hypercholesterolemia; Myocardial infarction; P selectin

Indexed keywords

BRADYKININ B2 RECEPTOR; QUINAPRIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032942266     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.3.434     Document Type: Article

References (30)

1. Ma X-L, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72:403-412.
2. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after myocardial ischemia and reperfusion in dogs. Circulation. 1993;88: 2337-2350.
3. Mancini GBJ, Henry GC, Macaya C. O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Kubaner MI, Harber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996;94:258-265.
4. Chobanian AV, Haudenshild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15:327-331.
5. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest. 1993;91:1453-1458.
6. Jacobson LS, Persson K, Aberg G, Andersson RGG, Karlberg BE, Olsson AG. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J Cardiovasc Pharmacol. 1994;24:670-677.
7. Hoshida S, Nishida M, Yamashita N, Igarashi J, Aoki K, Hori M, Kuzuya T, Tada M. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril. Atherosclerosis. 1997;130:53-59.
8. Becker RHA, Weimer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol. 1991;18 (suppl 2):S110-S115.
9. Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation. 1987;75:292-298.
10. Golino P, Maroko PR, Carew TE. Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation. 1987;76:173-180.
11. Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest. 1989;83:465-473.
12. Hoshida S, Nishida M, Yamashita N, Igarashi J, Hori M, Kuzuya T, Tada M. Amelioration of the severity of myocardial injury by a nitric oxide donor in rabbits fed a cholesterol-rich diet. J Am Coll Cardiol. 1996;27: 902-909.
13. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kuzuya T, Tada M. A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia. J Pharmacol Exp Ther. 1996;278:741-746.
14. Hoshida S, Yamashita N, Igarashi J, Aoki K, Kuzuya T, Hori M. Long-term probucol treatment reverses the severity of myocardial injury in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 1997;17:2801-2807.
15. Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells: possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res. 1996;78:780-789.
16. Gauthier TW, Davenpeck KL, Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol. 1994;267:G562-G568.
17. Lehr H-A, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 1994;71:380-386.
18. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 1991;112:749-759.
19. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
20. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kamada T, Kuzuya T, Tada M. Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther. 1995;274: 413-418.
21. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1970;20:1637-1648.
22. Johnston CI, Mendelsohn FAO, Cubela RB, Jackson B, Kohzuki M, Fabris B. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors. J Hypertension. 1988;6(suppl 3):S17-S22.
23. Heimburger M, Palmblad JE. Effect of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils. Clin Exp Immunol. 1996;103:454-460.
24. Hoshida S, Yamashita N, Igarashi J, Nishida M, Aoki K, Kuzuya T, Tada M. Augmentation of infarct size and myocardial angiotensin-converting enzyme activity in atherosclerotic rabbits: effects of chronic treatment with enalapril. Circulation. 1996;94(suppl I):I-607. Abstract.
25. Weyrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol. 1995;57:45-55.
26. Lefer DJ, Flynn DM, Anderson DC, Buda AJ. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am J Physiol. 1996;271:H2421-H2429.
27. Martonrana PA, Kettenbach B, Breipohl G, Linz W, Scholkens BA. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 1990; 182:395-396.
28. Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE140. J Cardiovasc Pharmacol. 1993;21:996-1003.
29. Liang C, Gavras H, Black J, Sherman LG, Hood WB. Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effect of systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size. Circulation. 1982;66:1249-1255.
30. Miki T, Miura T, Shimamoto K, Urabe K, Sakamoto J, Iimura O. D angiotensin converting enzyme inhibitors limit myocardial infarct size Clin Exp Pharmacol Physiol. 1993;20:429-434.